Treatment of acute kidney injury with cast nephropathy

Clinical Nephrology
|April 15, 2014
PubMed

Insights

Multiple myeloma patients with kidney injury need better treatments. While newer chemotherapy is promising, extended high cut-off hemodialysis (HCO-HD) shows potential for removing harmful proteins, but requires more study.

Area of Science:

  • Nephrology
  • Oncology
  • Renal Medicine

Background:

  • Multiple myeloma frequently causes renal disease, primarily acute kidney injury (AKI) from cast nephropathy.
  • AKI in myeloma significantly worsens patient survival and limits treatment options, highlighting the need for effective therapies.
  • Cast nephropathy arises from filtered free light chains (FLCs) and Tamm-Horsfall protein (THP) aggregation, causing tubular obstruction.

Purpose of the Study:

  • To review the role of extracorporeal therapies in managing cast nephropathy in multiple myeloma.
  • To evaluate the efficacy of extended high cut-off hemodialysis (HCO-HD) compared to previous methods like therapeutic plasma exchange (TPE).

Main Methods:

  • Review of existing literature on extracorporeal therapies for myeloma kidney.
  • Analysis of trials involving therapeutic plasma exchange (TPE) and extended high cut-off hemodialysis (HCO-HD).

Main Results:

  • Therapeutic plasma exchange (TPE) has not demonstrated clear renal benefits in larger trials.
  • Extended high cut-off hemodialysis (HCO-HD) shows encouraging results in preliminary studies for removing FLCs.
  • No randomized trials currently confirm HCO-HD's benefit when added to modern chemotherapy regimens.

Conclusions:

  • Rapid reduction of FLCs is crucial for renal recovery in cast nephropathy.
  • While HCO-HD is a promising extracorporeal therapy for FLC removal, its role as standard care alongside chemotherapy is not yet established.
  • Further randomized trials are necessary to validate the benefits of HCO-HD in multiple myeloma patients with renal disease.

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
788
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K